MedPath

High Flow Nasal Cannula for Safe Apnea

Not Applicable
Completed
Conditions
Anesthesia, General
Apnea
Interventions
Device: Buccal oxygenation
Device: High flow nasal cannula
Registration Number
NCT04849520
Lead Sponsor
Seoul National University Hospital
Brief Summary

This is a prospective randomized controlled trial comparing high flow nasal cannula and buccal oxygenation as method of oxygenation during apnea in children.

Detailed Description

This is a prospective randomized controlled trial comparing two oxygenation methods for prolongation of apnea time in children aged 0 to 10 years old.

This study measures time for the pulse oximetry drop from 100% to 92% after oxygenation with 100% oxygen, applying high flow nasal cannula or buccal oxygen insufflation via an oral Ring-Adair-Elwyn endotracheal tube connected to oxygen.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Children under 11 years old undergoing general anesthesia with American Society of Anesthesiologists Physical Status 1 or 2.
Exclusion Criteria
  • Refusal of enrollment from one or more legal guardians of the patient
  • Plan of usage of supraglottic airway device as airway maintenance device
  • Presence of upper respiratory tract infection of lung disease
  • Premature infants younger than postconceptual age of 40 weeks
  • Anticipation of difficult bag-mask ventilation due to facial anomaly or micrognathia
  • Other conditions that are considered inappropriate for the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BuccalBuccal oxygenationApplication of buccal oxygenation during apnea
High flowHigh flow nasal cannulaApplication of high flow nasal cannula during apnea
Primary Outcome Measures
NameTimeMethod
Apnea success rateFrom start of apnea to drop of pulse oximetry to 92%, up to 520 seconds

Proportion of patients that succeed in prolongation of apnea time while maintaining pulse oximetry \> 92%

Secondary Outcome Measures
NameTimeMethod
End-tidal carbon dioxideAfter resuming of bag-mask ventilation, up to 30 seconds

End-tidal carbon dioxide partial pressure of first resumed breath after apnea

Pulse oximetryFrom start of study to end of study, up to 20 min

Pulse oximetry measured throughout the study

Apnea timeFrom start of apnea to drop of pulse oximetry to 92%, up to 520 seconds

Time elapsed from start of apnea to resume of bag-mask ventilation

Time to pulse oximetry of 100 percentAfter resuming of bag-mask ventilation, up to 300 seconds

Time elapsed from resume of bag-mask ventilation to regain of 100 percent in the pulse oximetry value

Minimal pulse oximetryAfter resuming of bag-mask ventilation, up to 60 seconds

Lowest value of pulse oximetry after resume of bag-mask ventilation

ElectrocardiogramFrom start of study to end of study, up to 20 min

Appearance of any arrhythmia or prolonged QT interval measured throughout the study

Mean blood pressureFrom start of study to end of study, up to 20 min

Mean non-invasive blood pressure measured throughout the study

Oxygen reserve indexFrom start of study to end of study, up to 20 min

Oxygen reserve index measured throughout the study

Transcutaneous carbon dioxideFrom start of study to end of study, up to 20 min

Transcutaneous carbon dioxide level measured throughout the study

Heart rateFrom start of study to end of study, up to 20 min

Heart rate measured throughout the study

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath